December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
|
|
|
- Adrian Craig
- 9 years ago
- Views:
Transcription
1 December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage in-house capabilities to produce digital campaign materials and instead turn to external agencies. The digital agency landscape is crowded with specialist firms, large full-service organizations, and traditional consultancies moving into the creative space, making it difficult for marketing managers to identify which of the many players are the true pros. To find a good agency, pharma marketers rely on their colleagues, mainly in procurement. Once they have assembled a short list, marketers make their final selection by looking for the agency that best understands their business needs and exhibits creativity and strategic thinking. These characteristics matter more than an agency s reputation, previous collaboration, or client references. Table of Contents Pharma Marketers Use A Mix Of Tools To Find And Select Digital Agencies Methodology Online survey with 41 marketing managers (brand managers, brand directors, marketing directors) in global pharmaceutical companies 2 7 Companies Surveyed For This Report AbbVie, AstraZeneca, Bayer, Boehringer- Ingelheim, Bristol-Myers Squibb, Eli Lilly, Ferring Pharmaceuticals, GlaxoSmithKline, Leo Pharma, Merck, Novartis, Pfizer, Roche, Shire, UCB 7
2 PHARMA MARKETERS USE A MIX OF TOOLS TO FIND AND SELECT DIGITAL AGENCIES We surveyed forty-one marketing managers to understand how they found and selected a marketing agency to produce their latest digital campaign material (see Figure 1). Identifying the true pros in a crowded field of agencies is difficult for most marketing teams, but it s very important given the agency s vital role in the overall campaign. Our survey found that most marketing managers: Short-list based on recommendations from procurement and colleagues. On average, marketers use three sources of information to find digital marketing agencies to put on their short list (see Figure 2). Seventy-three percent of marketing managers pick agencies from their procurement department s preferred supplier list; two-thirds ask their colleagues for a recommendation. Agencies that the company has previously used, or is currently using, to deliver a digital marketing campaign also stand a good chance of being selected. On the other end of the spectrum, marketing managers report that cold-calling, white papers, trade magazine promotions, and social media campaigns have very little influence on their decision to short-list an agency. Choose the agency with the best strategic thinking and needs assessment. On average, marketing managers use four criteria to evaluate the offerings of shortlisted digital marketing agencies (see Figure 3). When examining agency proposals and pitch documents, brand managers primarily look at whether the agency displays strong strategic and creative thinking. Forty-nine percent of marketing managers think that it s very important that the agency understands their business needs. Other factors that play a key role are the cost-effectiveness of the proposed solution and the agency s technical skills and capacity for innovation. Conversely, neither previous collaboration with an agency nor an agency s list of client references and case studies are of much importance. Face obstacles with on-time, within-budget delivery. About one-quarter to onethird of marketing managers see the agency they selected struggle to keep to deadlines and budgets once the project is underway (see Figure 4). Another strong roadblock is agencies lack of attention to detail in the final campaign deliverables. When marketers selected an agency primarily due to its strong strategic and creative thinking and skill in interpreting the business need, they generally found that they chose well those factors did not prove to be agency-side obstacles to getting the job done. Don t see outstanding digital agency performance. Marketing managers have to overcome multiple obstacles before actually getting their campaign material in hand. When we asked them to rate the digital agency they selected and applied the Net Promoter Score methodology, the consequences of this struggle became clear: with an overall NPS of 31, very few marketers would actively recommend the agency they used to colleagues asking for suggestions (see Figure 5). However, nearly half of our respondents gave their agencies a 7 or 8, which represents a reasonable level of customer satisfaction.
3 Figure 1: Pharma marketers turn to agencies for apps and MCM campaign support Figure 2: Pharma marketers use time-tested means to select digital agencies
4 Figure 3: Creativity and business savvy are the top characteristics that digital agencies need
5 Figure 4: On-time, within-budget delivery of well-executed projects challenge digital agencies
6 Figure 5: Digital agencies can t make their mark on customer satisfaction
7 METHODOLOGY DT Associates fielded its survey to forty-one marketing managers in pharmaceutical organizations using an online survey tool plus a personal invitation by . We fielded the survey from October 2014 to December Respondent incentives included a copy of this report and a donation to a charity. Our sample is not guaranteed to be representative of the population. Unless otherwise noted, data is intended for descriptive purposes. COMPANIES SURVEYED FOR THIS REPORT AbbVie AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly Ferring Pharmaceuticals GlaxoSmithKline Leo Pharma Merck Novartis Pfizer Roche Shire UCB
8 ABOUT THE AUTHORS Dennis van Rooij Dennis is a recognized expert on how pharmaceutical executives can take full advantage of new digital technologies to bolster their commercial objectives. He brings a strategic yet pragmatic perspective on digital channels for the healthcare vertical in general and the pharmaceutical industry in particular to every engagement. In his current role as Managing Partner, Dennis is responsible for managing client relationships with a number of leading global pharmaceutical companies and spends a significant amount of his time working directly with clients. Dennis was the Global Head of Digital Transformation and Acceleration at Novartis pharmaceutical based in Switzerland. He also served as an interim advisor for an innovative pharmaceutical company, supporting its global digital capabilities and engagement team. Prior to that, Dennis led the digital marketing strategy for Asia Pacific, Japan, and emerging markets for GlaxoSmithKline, where he earned the prestigious President s Award for innovative marketing in emerging markets. Dennis also has seven years of commercial and digital strategy experience outside the global pharmaceutical industry as a senior consultant at MetrixLab and Forrester Research, where he worked with many of the world s top companies. Tim van Tongeren For more than ten years, Tim has specialized in helping commercial and marketing leaders navigate the strategy and operational transformations required to deal with technology change. In his current role as Managing Partner, Tim spends most of his time managing our international associate network alongside his work with leading global pharmaceutical companies to improve their digital excellence. Tim s primary achievements include developing digital capabilities for marketing managers, setting a long-term digital strategy, and adjusting the brand planning process for digital excellence, all for Tier 1 pharmaceutical companies. Most recently, he has guided business leaders in formulating and implementing their digital road maps, making sure that they don t overlook the necessary change management elements of marketing organization digital transformation. Tim has an extensive background in management consulting across a number of industries, which supports his digital excellence work for healthcare companies. As a senior strategy consultant at global marketing agency SapientNitro, he worked with clients across industries to develop and execute digital marketing strategies. Prior to that, Tim was an analyst at Forrester Research, where he produced thought-provoking research on technology innovation and customer experience management when it was still a relatively new discipline. ABOUT DT ASSOCIATES DT Associates is a specialist digital consultancy that enables healthcare companies to achieve digital excellence an essential component of continued business success in an age of digital disruption. We help leading innovators in the healthcare and pharmaceutical industry successfully assess, launch, accelerate, and optimize digital excellence initiatives. DT Associates addresses firms digital business challenges in ways that no other consultancy can. Our clients face complex marketing and technology questions every day; we help them make the right decisions. DT Associates bespoke consulting services have a strong focus on digital marketing, strategy, and capabilities and our consultants bring deep digital and pharmaceutical knowledge and expertise to the table. Over the past ten years, we ve helped dozens of executives and teams at leading healthcare firms achieve digital success. Discover how we can partner with you to achieve digital excellence at prohibited. Information is based on best available resources. Opinions reflect judgment at the time and are subject to change.
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
Medical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
Websalad Connect. A fresh approach to digital marketing... PAGE 1
Websalad Connect A fresh approach to digital marketing... PAGE 1 2014 We connect B2B digitally across Asia Pacific Does your organisation require greater understanding and accountability from its digital
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
Pharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
3 rd Asia Pacific Pharmaceutical Compliance Congress And Best Practices Forum Sept 10-12 2013, Kuala Lumpur, Malaysia
3 rd Asia Pacific Pharmaceutical Compliance Congress And Best Practices Forum Sept 10-12 2013, Kuala Lumpur, Malaysia Mai Tran COMPLIANCE ISSUES IN SOCIAL MEDIA AND DIGITAL MARKETING Social media landscape
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Executive Checklist to Transitioning Processes
Digital Innovation Series Executive Checklist to Transitioning Processes Building a Flexible Model The Digital Innovation Series traces the trends that are driving the digital-innovation imperative that
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
Kea Influencer Relations and Marketing for High-Tech & Technology Providers
Kea Analyst Relations Industry analysts play a key role in defining markets and educating buyers. We work with clients to identify and track the most influential and relevant industry analysts, and advise
Serialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
Brochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
In the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
MBA in Supply Chain Management
MBA in Supply Chain Management MBA in Supply The effective supply chain has become a new organizational and operational model for the information age. Supply chain management is a business process that
Main Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation
Lead the Future of Pharmaceutical Science
MYLAN SCHOOL OF PHARMACY AND THE GRADUATE SCHOOL OF PHARMACEUTICAL SCIENCES Lead the Future of Pharmaceutical Science GRADUATE SCHOOL OF PHARMACEUTICAL SCIENCES: A NATIONAL LEADER ABOUT DUQUESNE UNIVERSITY
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
High impact recruitment solutions
High impact recruitment solutions Talent with impact About Futurestep We are the global industry leader in high impact recruitment solutions; offering fully customized, flexible services to help organizations
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
Total Compensation Measurement. Global TCM Participants. Turkey
Total Compensation Measurement 2008 Global TCM Participants Turkey Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for 2008. Measure
The power of creativity www.originbranding.com. Pharmaceutical Branding 2012
The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
Job Description. Context. Scope. Job Title. Assistant Digital Fundraising Manager. Job Band SAME Job Reference UKO55432
Job Description Job Title Assistant Digital Fundraising Manager Job Band SAME Job Reference UKO55432 Department Individual Giving Digital Fundraising Division Fundraising Location UK Office, London Duration
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar [email protected]
1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
Recruitment Process Outsourcing Market Segment: Overall
NEAT EVALUATION FOR CIELO: Recruitment Process Outsourcing Market Segment: Overall This document presents Cielo with the NelsonHall NEAT vendor evaluation for Recruitment Process Outsourcing (Overall market
Shaping the Future of Healthcare
Shaping the Future of Healthcare www.imsconsultinggroup.com Join a team of people who are committed to advancing healthcare IMS Consulting Group (IMSCG) is the leading global management consulting firm
Global Peptide Therapeutics Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences
Harness the Power of Partnership Everything is possible when you have the right partner.
Technology Success Accelerate Harness the Power of Partnership Everything is possible when you have the right partner. Avnet Technology Solutions, Americas Intelligent Collaboration Disruptive technologies
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
INTEGRATED MARKETING AGENCY DUBAI
INTEGRATED MARKETING AGENCY DUBAI We Are POSITION FIRST is a German/French Marketing Agency based in Dubai.. We provide clients with a full suite of integrated digital and traditional marketing services.
Why Choose Dundas Dashboard
Why Choose Dundas Dashboard Dundas Data Visualization, Inc. 250 Ferrand Drive, Suite 500 Toronto, ON Canada M3C 3G8 1.800.463.1492 1.416.467.9100 [email protected] www.dundas.com Table of Contents 1.0 Introduction
How To Manage A Focused Outreach Lead Generation Initiative
Focused Outreach Lead Generation to Produce High Quality Leads and Raise Your ROI By Elisa Ciarametaro of Exceed Sales www.exceedsales.com Elisa Ciarametaro and Exceed Sales, Inc. Table of Contents What
Readymade SharePoint Apps
www.adapt-india.com Adapt will help you discover the ultimate value behind your SharePoint investment, which is, how it can work with your existing environment and beyond. Adapt brings a unique blend of
Transforming Healthcare Delivery
Ibn Sina (Bldg 27), #301, Dubai Healthcare City, P.O.Box 8703, Dubai, UAE. Ph + 971 4 454 4631, Fax + 971 4 4546003. E-mail [email protected] Web www.eurohealth.ae Transforming Healthcare Delivery
Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
The Purpose of PR 2016
The Purpose of PR 2016 Research Report Contents Introduction Key findings Purpose of PR Tactics Budget Social media, SEO Media Relevance and importance of PR INTRODUCTION FROM XANTHE VAUGHAN WILLIAMS PR
Kyriacos Kokkinos IBM Executive Director Analytics Consulting
Kyriacos Kokkinos IBM Executive Director Analytics Consulting Contents CMO demographics The CMO s changing world The CMO s relationship with the C-suite Profiling the CMO What it takes for success in a
Manager for Social Sciences - 42897. External Relations. Full time. Permanent. External and internal candidates
Job Description Post Title and Post Number Organisation Advertising Description College Marketing and Communications Manager for Social Sciences - 42897 External Relations Post Number 42897 Full Time/Part
GE Capital The Net Promoter Score: A low-cost, high-impact way to analyze customer voices
GE Capital The Net Promoter Score: A low-cost, high-impact way to analyze customer voices The Net Promoter Score: A low cost, high impact way to analyze customer voices GE Capital s Net Promoter survey
Digital Marketing Services. Increasing Your Digital Footprint
Digital Marketing Services Increasing Your Digital Footprint IMS Marketing at a Glance ABOUT US Established in 2006, IMS Marketing is Ireland s only dedicated technical marketing company. Our specialist
Proof of Concept service. Professional and Managed Services. Installation services. First Looks
SUPPORT SERVICES Professional and Managed Services Exclusive Networks offers an extensive professional and managed services portfolio, which enables our business partners to successfully expand their product
FIRSTBASE ABACUS E-MEDIA: CONTENT MARKETING PLATFORM FOR LEAD GENERATION
FIRSTBASE ABACUS E-MEDIA: Category number: 8 Category name: Best use of content marketing Programme/initiative name: Abacus e-media: Content marketing platform for lead generation Agency: First Base Brand
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Philip S. Brewster Brewster Law Firm LLC July 29, 2014 Schering Charitable
Global Commercial Drug Supply for Trials: How to Achieve Long-term Success Published in Journal for Clinical Studies
How to Achieve Long-term Success Published in Journal for Clinical Studies For more information about sourcing in the US and EU, call +1 610.233.3300 or email [email protected] Myoderm is a leader in the
SANDY ROGERS Expert Consultant Practice Leader Thought Leader Speaker
SANDY ROGERS Expert Consultant Practice Leader Thought Leader Speaker Drive faster growth through a customer-centric culture. Dominate Your Competition by Making Every Store a Top Performer Change Frontline
HOW STRATEGIC ROADMAPPING ADDS VALUE
HOW STRATEGIC ROADMAPPING ADDS VALUE Irene J. Petrick, Ph.D. June 2010 In the past several years, I have actually heard several mid- to senior-level executives challenge their teams to drive for disruptive
Key Industry Challenges addressed by Superior Customer Offerings
Customer Value Enhancement Award Mobile Marketing North America, 2011 Frost & Sullivan s Global Research Platform Frost & Sullivan is in its 50th year in business with a global research organization of
DIRECTOR, FMCG and Retail. Working location: Ho Chi Minh City, Vietnam.
DIRECTOR, FMCG and Retail Working location: Ho Chi Minh City, Vietnam. 1 ABOUT US EPINION IS A MARKET RESEARCH AGENCY. We deliver fact-based insights to our clients, supporting significant decisions. WE
HOW TO INFLUENCE. A study of what influences technology purchasing decisions in financial institutions
HOW TO INFLUENCE FinTech BUYERS A study of what influences technology purchasing decisions in financial institutions Executive Summary Driven by shifting consumer behaviour, new market entrants and a raft
Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch
Pharmaceutical Products Liability Michael C. Dubin Stephen Knobloch Objectives Objective 1 Get Actuaries Thinking About Adding Value to New Areas Objective 2 Provide example using pharmaceutical industry
School Relations Manager, South Job Description
School Relations Manager, South Job Description About Teaching Leaders Teaching Leaders is an innovative not-for-profit organisation whose mission is to address educational disadvantage by growing a movement
TABLE OF COMMITMENTS
Reaching Goals On, a range of public and private partners are announcing a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by in support
Stakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
HOW CLOSE ARE YOU TO YOUR CUSTOMERS?
HOW CLOSE ARE YOU TO YOUR CUSTOMERS? You know what kind of people your customers are. You likely even know their names, how often they shop with you and what they ve bought recently. But can you say which
SAY NEW INVESTOR DEMANDS ARE RESHAPING THE COMPETiTIVE LANDSCAPE. Frontline Revolution: The New Battleground for Asset Managers
Frontline Revolution: The New Battleground for Asset Managers Asset managers are rethinking their business models to capitalize on new trends in investor demand, according to a State Street survey of 300
Payroll Operations and Information Management and Payroll Services Alliance Management Office Annual Report. November 2007
Payroll Operations and Information Management and Payroll Services Alliance Management Office Annual Report November 2007 1. Initiative Overview 2. Status Update 3. Appendix A: Contract Objectives 4. Appendix
Private Banking, Wealth Management
Private Banking, Wealth Management and Investment Awards 2014 Rule Book The Asset Triple A Private Banking, Wealth Management and Investment Awards 2014 Introduction The Asset s Triple A Private Banking,
Investing in the Global Marketplace: Opportunities in International Equities
Investing in the Global Marketplace: Opportunities in International Equities August 2014 Martin C. Schulz, J.D. Managing Director International Equity Now more than ever, international equity plays a critical
Transforming Data Into Business Value. Dr. Rado Kotorov Chief Innovation Officer & VP November 30th, 2015
Transforming Data Into Business Value Dr. Rado Kotorov Chief Innovation Officer & VP November 30th, 2015 1 Information Builders at a Glance Dedicated Software and Services Business Intelligence & Analytics
The Forrester Wave : Digital Agencies In China Strategy And Execution, Q1 2015
For: Marketing Leadership Professionals The Forrester Wave : Digital Agencies In China Strategy And Execution, Q1 2015 by Xiaofeng Wang, January 27, 2015 Key Takeaways OgilvyOne, Isobar, And Razorfish
